Clin Cancer Res:胃癌分子分型、预后及疗效的关系

2017-07-28 王强 肿瘤资讯

发表在美国癌症研究学会(American Association for Cancer Research)官方期刊Clinical Cancer Research上的一篇文章称,胃癌的四种分子分型有助于预测生存预后及患者的化疗效果,因此可能有望进一步精确指导治疗方案的制定。 德克萨斯大学MD安德森肿瘤中心癌症医学部系统生物学副教授Lee博士介绍道,胃癌大部分都会行手术治疗,其次行化疗。不过,这些

发表在美国癌症研究学会(American Association for Cancer Research)官方期刊Clinical Cancer Research上的一篇文章称,胃癌的四种分子分型有助于预测生存预后及患者的化疗效果,因此可能有望进一步精确指导治疗方案的制定。

德克萨斯大学MD安德森肿瘤中心癌症医学部系统生物学副教授Lee博士介绍道,胃癌大部分都会行手术治疗,其次行化疗。不过,这些患者的预后却有显着差异,当然预后差异可能是肿瘤生物学及分子方面有区别所致。但是,这些差异却尚未完全明了。

2014年,癌症基因图谱计划(The Cancer Genome Atlas,TCGA)揭示胃癌有四种分子亚型:EB病毒阳性型(EBV)、微卫星不稳定型(MSI)、基因组稳定型(GS)、染色体不稳定型(CIN)。为确定这四种亚型的临床意义,Lee博士等人重新分析了TCGA中胃癌部分四种亚型的基因表达数据。他们利用这些数据建立了一个预测模型,并对韩国的267例和MD安德森肿瘤中心的432例胃癌患者分别进行了模型验证。

总体而言,他们发现EB病毒阳性亚型在无复发生存和总生存方面预后最好,而基因组稳定型预后最差。微卫星不稳定型预后中等。染色体不稳定型预后也中等,但韩国的病例预后要差于MD安德森肿瘤中心病例。Lee说道,这表明染色体不稳定型的均质性可能稍差,因此很难确定其确切特征。

该研究同时尝试探索了辅助化疗对不同亚型的临床获益是否也有所不同。因为MD安德森肿瘤中心病例有半数以上进行了辅助化疗,因此这一问题仅对这部分病例进行了研究。结果表明染色体不稳定型患者化疗的获益最大:染色体不稳定型患者化疗后的3年无复发生存率为58.7%、而未化疗者这一比例仅为33.5%。

基因组稳定型患者未见化疗获益,而微卫星不稳定型患者具有中等程度获益;EB病毒阳性亚型患者无法进行化疗获益评估,因为这部分患者均进行了化疗,无法进行比较。

Lee说道,基因组稳定型患者化疗无获益是该研究中最引人注意的结果。“这意味着我们要针对这一亚型寻找新的治疗靶点和药物。”同时他补充道,基因组稳定型患者如果进行化疗,很可能没有什么效果,反而却会受化疗副作用之害!

Lee说道,该研究的结果表明,上述分类可能在临床医师决定患者最佳治疗方案时有一定指导作用。上述结论如果进一步证实,可能会为个体化治疗提供更多信息。“对每一种亚型的生物学特征了解越深入,将越有助于明确哪些患者可以自免疫治疗、化疗或其他治疗方案获益。”

针对上述结果,尚需前瞻性研究进一步证实。

评论

回顾人类和肿瘤斗争的历史,从传统草药、到化疗药物,从解剖部位为基础的外科手术、到微创手术,从普通放疗到精确放疗,从代谢性化疗药物到新兴的靶向药物、免疫治疗等,无不体现着“仅对部分患者有效”这一点。在基因组学和生物信息学迅速发展的当代,对“部分患者”进行精准筛选,应成为我们工作的重中之重,也是对抗肿瘤的新希望……

原始出处:

Bo Hwa Sohn, Jun-Eul Hwang, et al. Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project. Clinical Cancer Research Published OnlineFirst July 26, 2017 doi: 10.1158/1078-0432.CCR-16-2211

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=227845, encodeId=75b222e8457f, content=EB病毒阳性亚型在无复发生存和总生存方面预后最好,而基因组稳定型预后最差。微卫星不稳定型预后中等。染色体不稳定型预后也中等,但韩国的病例预后要差于MD安德森肿瘤中心病例。Lee说道,这表明染色体不稳定型的均质性可能稍差,因此很难确定其确切特征。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:39:10 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227844, encodeId=0b5222e844fb, content=癌症基因图谱计划(TheCancerGenomeAtlas,TCGA)揭示胃癌有四种分子亚型:EB病毒阳性型(EBV)、微卫星不稳定型(MSI)、基因组稳定型(GS)、染色体不稳定型(CIN)。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:38:38 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227627, encodeId=e7c022e62784, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jul 29 09:52:50 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227577, encodeId=2cb122e57748, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Sat Jul 29 08:19:26 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227558, encodeId=4fc422e55815, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=98dd1959726, createdName=游手好闲, createdTime=Sat Jul 29 07:55:41 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227541, encodeId=56af22e54105, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat Jul 29 07:35:30 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227500, encodeId=aa5a22e5005d, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jul 29 06:43:56 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227445, encodeId=0acf22e44592, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Jul 29 01:25:36 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227382, encodeId=c01222e382b1, content=很好的内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KynZWiaZcw1J0lWhzLtT6ukInjVSRV4un6UrPrs68caGt3cNk2qhwctOqMFPWlvwF4wkvtn7bTIOQ/0, createdBy=cca998055, createdName=nannanxyy, createdTime=Fri Jul 28 22:53:42 CST 2017, time=2017-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227349, encodeId=ce5022e3495d, content=回顾人类和肿瘤斗争的历史,从传统草药、到化疗药物,从解剖部位为基础的外科手术、到微创手术,从普通放疗到精确放疗,从代谢性化疗药物到新兴的靶向药物、免疫治疗等,无不体现着“仅对部分患者有效”这一点。在基因组学和生物信息学迅速发展的当代,对“部分患者”进行精准筛选,应成为我们工作的重中之重,也是对抗肿瘤的新希望……, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri Jul 28 21:16:16 CST 2017, time=2017-07-28, status=1, ipAttribution=)]
    2017-07-30 随梦飞扬

    EB病毒阳性亚型在无复发生存和总生存方面预后最好,而基因组稳定型预后最差。微卫星不稳定型预后中等。染色体不稳定型预后也中等,但韩国的病例预后要差于MD安德森肿瘤中心病例。Lee说道,这表明染色体不稳定型的均质性可能稍差,因此很难确定其确切特征。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=227845, encodeId=75b222e8457f, content=EB病毒阳性亚型在无复发生存和总生存方面预后最好,而基因组稳定型预后最差。微卫星不稳定型预后中等。染色体不稳定型预后也中等,但韩国的病例预后要差于MD安德森肿瘤中心病例。Lee说道,这表明染色体不稳定型的均质性可能稍差,因此很难确定其确切特征。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:39:10 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227844, encodeId=0b5222e844fb, content=癌症基因图谱计划(TheCancerGenomeAtlas,TCGA)揭示胃癌有四种分子亚型:EB病毒阳性型(EBV)、微卫星不稳定型(MSI)、基因组稳定型(GS)、染色体不稳定型(CIN)。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:38:38 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227627, encodeId=e7c022e62784, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jul 29 09:52:50 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227577, encodeId=2cb122e57748, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Sat Jul 29 08:19:26 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227558, encodeId=4fc422e55815, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=98dd1959726, createdName=游手好闲, createdTime=Sat Jul 29 07:55:41 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227541, encodeId=56af22e54105, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat Jul 29 07:35:30 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227500, encodeId=aa5a22e5005d, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jul 29 06:43:56 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227445, encodeId=0acf22e44592, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Jul 29 01:25:36 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227382, encodeId=c01222e382b1, content=很好的内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KynZWiaZcw1J0lWhzLtT6ukInjVSRV4un6UrPrs68caGt3cNk2qhwctOqMFPWlvwF4wkvtn7bTIOQ/0, createdBy=cca998055, createdName=nannanxyy, createdTime=Fri Jul 28 22:53:42 CST 2017, time=2017-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227349, encodeId=ce5022e3495d, content=回顾人类和肿瘤斗争的历史,从传统草药、到化疗药物,从解剖部位为基础的外科手术、到微创手术,从普通放疗到精确放疗,从代谢性化疗药物到新兴的靶向药物、免疫治疗等,无不体现着“仅对部分患者有效”这一点。在基因组学和生物信息学迅速发展的当代,对“部分患者”进行精准筛选,应成为我们工作的重中之重,也是对抗肿瘤的新希望……, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri Jul 28 21:16:16 CST 2017, time=2017-07-28, status=1, ipAttribution=)]
    2017-07-30 随梦飞扬

    癌症基因图谱计划(TheCancerGenomeAtlas,TCGA)揭示胃癌有四种分子亚型:EB病毒阳性型(EBV)、微卫星不稳定型(MSI)、基因组稳定型(GS)、染色体不稳定型(CIN)。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=227845, encodeId=75b222e8457f, content=EB病毒阳性亚型在无复发生存和总生存方面预后最好,而基因组稳定型预后最差。微卫星不稳定型预后中等。染色体不稳定型预后也中等,但韩国的病例预后要差于MD安德森肿瘤中心病例。Lee说道,这表明染色体不稳定型的均质性可能稍差,因此很难确定其确切特征。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:39:10 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227844, encodeId=0b5222e844fb, content=癌症基因图谱计划(TheCancerGenomeAtlas,TCGA)揭示胃癌有四种分子亚型:EB病毒阳性型(EBV)、微卫星不稳定型(MSI)、基因组稳定型(GS)、染色体不稳定型(CIN)。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:38:38 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227627, encodeId=e7c022e62784, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jul 29 09:52:50 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227577, encodeId=2cb122e57748, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Sat Jul 29 08:19:26 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227558, encodeId=4fc422e55815, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=98dd1959726, createdName=游手好闲, createdTime=Sat Jul 29 07:55:41 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227541, encodeId=56af22e54105, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat Jul 29 07:35:30 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227500, encodeId=aa5a22e5005d, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jul 29 06:43:56 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227445, encodeId=0acf22e44592, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Jul 29 01:25:36 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227382, encodeId=c01222e382b1, content=很好的内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KynZWiaZcw1J0lWhzLtT6ukInjVSRV4un6UrPrs68caGt3cNk2qhwctOqMFPWlvwF4wkvtn7bTIOQ/0, createdBy=cca998055, createdName=nannanxyy, createdTime=Fri Jul 28 22:53:42 CST 2017, time=2017-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227349, encodeId=ce5022e3495d, content=回顾人类和肿瘤斗争的历史,从传统草药、到化疗药物,从解剖部位为基础的外科手术、到微创手术,从普通放疗到精确放疗,从代谢性化疗药物到新兴的靶向药物、免疫治疗等,无不体现着“仅对部分患者有效”这一点。在基因组学和生物信息学迅速发展的当代,对“部分患者”进行精准筛选,应成为我们工作的重中之重,也是对抗肿瘤的新希望……, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri Jul 28 21:16:16 CST 2017, time=2017-07-28, status=1, ipAttribution=)]
    2017-07-29 三生有幸9135

    学习一下谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=227845, encodeId=75b222e8457f, content=EB病毒阳性亚型在无复发生存和总生存方面预后最好,而基因组稳定型预后最差。微卫星不稳定型预后中等。染色体不稳定型预后也中等,但韩国的病例预后要差于MD安德森肿瘤中心病例。Lee说道,这表明染色体不稳定型的均质性可能稍差,因此很难确定其确切特征。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:39:10 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227844, encodeId=0b5222e844fb, content=癌症基因图谱计划(TheCancerGenomeAtlas,TCGA)揭示胃癌有四种分子亚型:EB病毒阳性型(EBV)、微卫星不稳定型(MSI)、基因组稳定型(GS)、染色体不稳定型(CIN)。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:38:38 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227627, encodeId=e7c022e62784, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jul 29 09:52:50 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227577, encodeId=2cb122e57748, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Sat Jul 29 08:19:26 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227558, encodeId=4fc422e55815, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=98dd1959726, createdName=游手好闲, createdTime=Sat Jul 29 07:55:41 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227541, encodeId=56af22e54105, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat Jul 29 07:35:30 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227500, encodeId=aa5a22e5005d, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jul 29 06:43:56 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227445, encodeId=0acf22e44592, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Jul 29 01:25:36 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227382, encodeId=c01222e382b1, content=很好的内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KynZWiaZcw1J0lWhzLtT6ukInjVSRV4un6UrPrs68caGt3cNk2qhwctOqMFPWlvwF4wkvtn7bTIOQ/0, createdBy=cca998055, createdName=nannanxyy, createdTime=Fri Jul 28 22:53:42 CST 2017, time=2017-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227349, encodeId=ce5022e3495d, content=回顾人类和肿瘤斗争的历史,从传统草药、到化疗药物,从解剖部位为基础的外科手术、到微创手术,从普通放疗到精确放疗,从代谢性化疗药物到新兴的靶向药物、免疫治疗等,无不体现着“仅对部分患者有效”这一点。在基因组学和生物信息学迅速发展的当代,对“部分患者”进行精准筛选,应成为我们工作的重中之重,也是对抗肿瘤的新希望……, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri Jul 28 21:16:16 CST 2017, time=2017-07-28, status=1, ipAttribution=)]
    2017-07-29 130****4638

    学习了谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=227845, encodeId=75b222e8457f, content=EB病毒阳性亚型在无复发生存和总生存方面预后最好,而基因组稳定型预后最差。微卫星不稳定型预后中等。染色体不稳定型预后也中等,但韩国的病例预后要差于MD安德森肿瘤中心病例。Lee说道,这表明染色体不稳定型的均质性可能稍差,因此很难确定其确切特征。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:39:10 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227844, encodeId=0b5222e844fb, content=癌症基因图谱计划(TheCancerGenomeAtlas,TCGA)揭示胃癌有四种分子亚型:EB病毒阳性型(EBV)、微卫星不稳定型(MSI)、基因组稳定型(GS)、染色体不稳定型(CIN)。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:38:38 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227627, encodeId=e7c022e62784, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jul 29 09:52:50 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227577, encodeId=2cb122e57748, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Sat Jul 29 08:19:26 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227558, encodeId=4fc422e55815, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=98dd1959726, createdName=游手好闲, createdTime=Sat Jul 29 07:55:41 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227541, encodeId=56af22e54105, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat Jul 29 07:35:30 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227500, encodeId=aa5a22e5005d, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jul 29 06:43:56 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227445, encodeId=0acf22e44592, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Jul 29 01:25:36 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227382, encodeId=c01222e382b1, content=很好的内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KynZWiaZcw1J0lWhzLtT6ukInjVSRV4un6UrPrs68caGt3cNk2qhwctOqMFPWlvwF4wkvtn7bTIOQ/0, createdBy=cca998055, createdName=nannanxyy, createdTime=Fri Jul 28 22:53:42 CST 2017, time=2017-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227349, encodeId=ce5022e3495d, content=回顾人类和肿瘤斗争的历史,从传统草药、到化疗药物,从解剖部位为基础的外科手术、到微创手术,从普通放疗到精确放疗,从代谢性化疗药物到新兴的靶向药物、免疫治疗等,无不体现着“仅对部分患者有效”这一点。在基因组学和生物信息学迅速发展的当代,对“部分患者”进行精准筛选,应成为我们工作的重中之重,也是对抗肿瘤的新希望……, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri Jul 28 21:16:16 CST 2017, time=2017-07-28, status=1, ipAttribution=)]
    2017-07-29 游手好闲

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=227845, encodeId=75b222e8457f, content=EB病毒阳性亚型在无复发生存和总生存方面预后最好,而基因组稳定型预后最差。微卫星不稳定型预后中等。染色体不稳定型预后也中等,但韩国的病例预后要差于MD安德森肿瘤中心病例。Lee说道,这表明染色体不稳定型的均质性可能稍差,因此很难确定其确切特征。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:39:10 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227844, encodeId=0b5222e844fb, content=癌症基因图谱计划(TheCancerGenomeAtlas,TCGA)揭示胃癌有四种分子亚型:EB病毒阳性型(EBV)、微卫星不稳定型(MSI)、基因组稳定型(GS)、染色体不稳定型(CIN)。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:38:38 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227627, encodeId=e7c022e62784, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jul 29 09:52:50 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227577, encodeId=2cb122e57748, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Sat Jul 29 08:19:26 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227558, encodeId=4fc422e55815, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=98dd1959726, createdName=游手好闲, createdTime=Sat Jul 29 07:55:41 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227541, encodeId=56af22e54105, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat Jul 29 07:35:30 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227500, encodeId=aa5a22e5005d, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jul 29 06:43:56 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227445, encodeId=0acf22e44592, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Jul 29 01:25:36 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227382, encodeId=c01222e382b1, content=很好的内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KynZWiaZcw1J0lWhzLtT6ukInjVSRV4un6UrPrs68caGt3cNk2qhwctOqMFPWlvwF4wkvtn7bTIOQ/0, createdBy=cca998055, createdName=nannanxyy, createdTime=Fri Jul 28 22:53:42 CST 2017, time=2017-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227349, encodeId=ce5022e3495d, content=回顾人类和肿瘤斗争的历史,从传统草药、到化疗药物,从解剖部位为基础的外科手术、到微创手术,从普通放疗到精确放疗,从代谢性化疗药物到新兴的靶向药物、免疫治疗等,无不体现着“仅对部分患者有效”这一点。在基因组学和生物信息学迅速发展的当代,对“部分患者”进行精准筛选,应成为我们工作的重中之重,也是对抗肿瘤的新希望……, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri Jul 28 21:16:16 CST 2017, time=2017-07-28, status=1, ipAttribution=)]
    2017-07-29 龙胆草

    学习谢谢分享

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=227845, encodeId=75b222e8457f, content=EB病毒阳性亚型在无复发生存和总生存方面预后最好,而基因组稳定型预后最差。微卫星不稳定型预后中等。染色体不稳定型预后也中等,但韩国的病例预后要差于MD安德森肿瘤中心病例。Lee说道,这表明染色体不稳定型的均质性可能稍差,因此很难确定其确切特征。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:39:10 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227844, encodeId=0b5222e844fb, content=癌症基因图谱计划(TheCancerGenomeAtlas,TCGA)揭示胃癌有四种分子亚型:EB病毒阳性型(EBV)、微卫星不稳定型(MSI)、基因组稳定型(GS)、染色体不稳定型(CIN)。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:38:38 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227627, encodeId=e7c022e62784, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jul 29 09:52:50 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227577, encodeId=2cb122e57748, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Sat Jul 29 08:19:26 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227558, encodeId=4fc422e55815, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=98dd1959726, createdName=游手好闲, createdTime=Sat Jul 29 07:55:41 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227541, encodeId=56af22e54105, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat Jul 29 07:35:30 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227500, encodeId=aa5a22e5005d, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jul 29 06:43:56 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227445, encodeId=0acf22e44592, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Jul 29 01:25:36 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227382, encodeId=c01222e382b1, content=很好的内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KynZWiaZcw1J0lWhzLtT6ukInjVSRV4un6UrPrs68caGt3cNk2qhwctOqMFPWlvwF4wkvtn7bTIOQ/0, createdBy=cca998055, createdName=nannanxyy, createdTime=Fri Jul 28 22:53:42 CST 2017, time=2017-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227349, encodeId=ce5022e3495d, content=回顾人类和肿瘤斗争的历史,从传统草药、到化疗药物,从解剖部位为基础的外科手术、到微创手术,从普通放疗到精确放疗,从代谢性化疗药物到新兴的靶向药物、免疫治疗等,无不体现着“仅对部分患者有效”这一点。在基因组学和生物信息学迅速发展的当代,对“部分患者”进行精准筛选,应成为我们工作的重中之重,也是对抗肿瘤的新希望……, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri Jul 28 21:16:16 CST 2017, time=2017-07-28, status=1, ipAttribution=)]
    2017-07-29 ylzr123

    好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=227845, encodeId=75b222e8457f, content=EB病毒阳性亚型在无复发生存和总生存方面预后最好,而基因组稳定型预后最差。微卫星不稳定型预后中等。染色体不稳定型预后也中等,但韩国的病例预后要差于MD安德森肿瘤中心病例。Lee说道,这表明染色体不稳定型的均质性可能稍差,因此很难确定其确切特征。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:39:10 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227844, encodeId=0b5222e844fb, content=癌症基因图谱计划(TheCancerGenomeAtlas,TCGA)揭示胃癌有四种分子亚型:EB病毒阳性型(EBV)、微卫星不稳定型(MSI)、基因组稳定型(GS)、染色体不稳定型(CIN)。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:38:38 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227627, encodeId=e7c022e62784, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jul 29 09:52:50 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227577, encodeId=2cb122e57748, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Sat Jul 29 08:19:26 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227558, encodeId=4fc422e55815, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=98dd1959726, createdName=游手好闲, createdTime=Sat Jul 29 07:55:41 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227541, encodeId=56af22e54105, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat Jul 29 07:35:30 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227500, encodeId=aa5a22e5005d, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jul 29 06:43:56 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227445, encodeId=0acf22e44592, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Jul 29 01:25:36 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227382, encodeId=c01222e382b1, content=很好的内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KynZWiaZcw1J0lWhzLtT6ukInjVSRV4un6UrPrs68caGt3cNk2qhwctOqMFPWlvwF4wkvtn7bTIOQ/0, createdBy=cca998055, createdName=nannanxyy, createdTime=Fri Jul 28 22:53:42 CST 2017, time=2017-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227349, encodeId=ce5022e3495d, content=回顾人类和肿瘤斗争的历史,从传统草药、到化疗药物,从解剖部位为基础的外科手术、到微创手术,从普通放疗到精确放疗,从代谢性化疗药物到新兴的靶向药物、免疫治疗等,无不体现着“仅对部分患者有效”这一点。在基因组学和生物信息学迅速发展的当代,对“部分患者”进行精准筛选,应成为我们工作的重中之重,也是对抗肿瘤的新希望……, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri Jul 28 21:16:16 CST 2017, time=2017-07-28, status=1, ipAttribution=)]
    2017-07-29 suibian2007bbb

    学习

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=227845, encodeId=75b222e8457f, content=EB病毒阳性亚型在无复发生存和总生存方面预后最好,而基因组稳定型预后最差。微卫星不稳定型预后中等。染色体不稳定型预后也中等,但韩国的病例预后要差于MD安德森肿瘤中心病例。Lee说道,这表明染色体不稳定型的均质性可能稍差,因此很难确定其确切特征。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:39:10 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227844, encodeId=0b5222e844fb, content=癌症基因图谱计划(TheCancerGenomeAtlas,TCGA)揭示胃癌有四种分子亚型:EB病毒阳性型(EBV)、微卫星不稳定型(MSI)、基因组稳定型(GS)、染色体不稳定型(CIN)。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:38:38 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227627, encodeId=e7c022e62784, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jul 29 09:52:50 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227577, encodeId=2cb122e57748, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Sat Jul 29 08:19:26 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227558, encodeId=4fc422e55815, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=98dd1959726, createdName=游手好闲, createdTime=Sat Jul 29 07:55:41 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227541, encodeId=56af22e54105, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat Jul 29 07:35:30 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227500, encodeId=aa5a22e5005d, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jul 29 06:43:56 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227445, encodeId=0acf22e44592, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Jul 29 01:25:36 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227382, encodeId=c01222e382b1, content=很好的内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KynZWiaZcw1J0lWhzLtT6ukInjVSRV4un6UrPrs68caGt3cNk2qhwctOqMFPWlvwF4wkvtn7bTIOQ/0, createdBy=cca998055, createdName=nannanxyy, createdTime=Fri Jul 28 22:53:42 CST 2017, time=2017-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227349, encodeId=ce5022e3495d, content=回顾人类和肿瘤斗争的历史,从传统草药、到化疗药物,从解剖部位为基础的外科手术、到微创手术,从普通放疗到精确放疗,从代谢性化疗药物到新兴的靶向药物、免疫治疗等,无不体现着“仅对部分患者有效”这一点。在基因组学和生物信息学迅速发展的当代,对“部分患者”进行精准筛选,应成为我们工作的重中之重,也是对抗肿瘤的新希望……, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri Jul 28 21:16:16 CST 2017, time=2017-07-28, status=1, ipAttribution=)]
    2017-07-28 nannanxyy

    很好的内容

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=227845, encodeId=75b222e8457f, content=EB病毒阳性亚型在无复发生存和总生存方面预后最好,而基因组稳定型预后最差。微卫星不稳定型预后中等。染色体不稳定型预后也中等,但韩国的病例预后要差于MD安德森肿瘤中心病例。Lee说道,这表明染色体不稳定型的均质性可能稍差,因此很难确定其确切特征。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:39:10 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227844, encodeId=0b5222e844fb, content=癌症基因图谱计划(TheCancerGenomeAtlas,TCGA)揭示胃癌有四种分子亚型:EB病毒阳性型(EBV)、微卫星不稳定型(MSI)、基因组稳定型(GS)、染色体不稳定型(CIN)。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Sun Jul 30 00:38:38 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227627, encodeId=e7c022e62784, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Jul 29 09:52:50 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227577, encodeId=2cb122e57748, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Sat Jul 29 08:19:26 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227558, encodeId=4fc422e55815, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=98dd1959726, createdName=游手好闲, createdTime=Sat Jul 29 07:55:41 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227541, encodeId=56af22e54105, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat Jul 29 07:35:30 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227500, encodeId=aa5a22e5005d, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jul 29 06:43:56 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227445, encodeId=0acf22e44592, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Jul 29 01:25:36 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227382, encodeId=c01222e382b1, content=很好的内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KynZWiaZcw1J0lWhzLtT6ukInjVSRV4un6UrPrs68caGt3cNk2qhwctOqMFPWlvwF4wkvtn7bTIOQ/0, createdBy=cca998055, createdName=nannanxyy, createdTime=Fri Jul 28 22:53:42 CST 2017, time=2017-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=227349, encodeId=ce5022e3495d, content=回顾人类和肿瘤斗争的历史,从传统草药、到化疗药物,从解剖部位为基础的外科手术、到微创手术,从普通放疗到精确放疗,从代谢性化疗药物到新兴的靶向药物、免疫治疗等,无不体现着“仅对部分患者有效”这一点。在基因组学和生物信息学迅速发展的当代,对“部分患者”进行精准筛选,应成为我们工作的重中之重,也是对抗肿瘤的新希望……, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri Jul 28 21:16:16 CST 2017, time=2017-07-28, status=1, ipAttribution=)]
    2017-07-28 有备才能无患

    回顾人类和肿瘤斗争的历史,从传统草药、到化疗药物,从解剖部位为基础的外科手术、到微创手术,从普通放疗到精确放疗,从代谢性化疗药物到新兴的靶向药物、免疫治疗等,无不体现着“仅对部分患者有效”这一点。在基因组学和生物信息学迅速发展的当代,对“部分患者”进行精准筛选,应成为我们工作的重中之重,也是对抗肿瘤的新希望……

    0

相关资讯

《胃癌腹膜转移防治中国专家共识》颁布——推动胃癌腹膜转移的规范化诊断与治疗

本次共识基于既往循证医学研究和临床实践,综合我国胃癌领域百余位专家的科研及临床经验进行撰写,具有简单实用、科学严谨和普适性等特点,从腹膜转移的诊断与分期、预防的主要手段及发生腹膜转移后的治疗等方面进行诠释,以期让广大临床医师更好地理解并加以运用。

Gut:表皮生长因子抑制剂可预防幽门螺杆菌感染导致的胃癌变

研究证实表皮生长因子抑制剂可预防幽门螺杆菌感染导致的胃癌变

JAMA Surg:胃腺癌全胃切除术后住院费用与并发症的关系

根治性全胃切除术后重度并发症患者术后费用增加了3倍,大部分的额外费用与并发症的治疗有关。术后并发症预防有助于节约医疗成本

HMGA2-FOXL2轴调节化疗抵抗胃癌的远处转移及上皮间质化

化疗是晚期肿瘤的主要治疗策略。化疗可以减轻肿瘤负担并延长患者生存期,其治疗效果已得到证实。但是大部分患者最终会出现化疗抵抗。化疗抵抗是肿瘤治疗过程中失败的主要原因,且与远处转移和上皮间质化(EMT)有关。CLIN CANCER RES近期发表了一篇文章,研究化疗抵抗胃癌远处转移及上皮间质化机制。

Br J Cancer:胃癌血清微小RNA生物标志物评估:miR-21和miR-331的重要性

胃癌(GC)是全球第三大癌症和全球重大的公共医疗保健问题,其中包括西方人群。 一些亚洲国家只有少数有限的早期检测诊断方法而且没有有效的筛查方案。 因此,大多数病例被诊断为晚期,预后不佳。 因此,迫切需要寻找新的、非侵入性的生物标志物,以便早期检测GC。 高稳定性和疾病特异性的错配表明体液中存在的微小RNA分子(miRNA),非常适用于包括胃癌(GC)在内的诊断应用。 然而,GC中循环miRN

中国实用护理杂志:一例胃癌根治术后二次吻合口瘘的护理

来源:中国实用护理杂志, 2016,32(10): 772-774.胃癌是世界范围内第二大常见癌症,在全国范围内发病率及病死率都很高。手术治疗是最佳的治疗方式,但手术并发症发生率也很高。吻合口瘘是威胁胃癌手术后恢复的最严重并发症,二次吻合口瘘则是胃癌术后罕见但严重的并发症,如处理不当,病死率为28.5%~71.0%[1]。二次吻合口瘘的整个过程,不仅住院时间长,经济负担重,而且治疗困难,患者遭